Reid Huber

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

Raised $138,999,773.00 from Cormorant Asset Management, Lilly Asia Ventures, Third Rock Ventures, Sirona Capital and Nextech Invest.

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Raised $250,000,000.00 from Sofinnova Investments, T. Rowe Price, Johnson & Johnson Innovation – JJDC, Surveyor Capital, Goldman Sachs Asset Management, Perceptive Advisors, Third Rock Ventures, Logos Capital, Fidelity and ARCH Venture Partners.

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

Raised $250,000,000.00 from Cormorant Capital, EcoR1 Capital, Novo Holdings, Third Rock Ventures and OrbiMed.

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

Raised $218,150,000.00 from Wellington Management, Bristol-Myers Squibb, Janus Henderson Investors, Boxer Capital, Third Rock Ventures, AstraZeneca and RA Capital Management.

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

Raised $643,000,000.00 from Alexandria Venture Investments, BlackRock, HOF Capital, CPP Investments, Google Ventures, Foresite Capital, Casdin Capital, Temasek Holdings, T. Rowe Price and Third Rock Ventures.